T lymphocytes as targets of gene transfer with Moloney-type retroviral vectors.

Standard

T lymphocytes as targets of gene transfer with Moloney-type retroviral vectors. / Ayuketang Ayuk, Francis; Zander, A R; Fehse, B.

in: CURR GENE THER, Jahrgang 1, Nr. 4, 4, 2001, S. 325-337.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{c88cc36ab74940abb74d2f9b2c391135,
title = "T lymphocytes as targets of gene transfer with Moloney-type retroviral vectors.",
abstract = "Peripheral T lymphocytes are a target of choice for many gene therapeutic strategies. Retrovirus-mediated transduction allows genomic integration and long-term expression of transgenes in target cells. Over many years, low transduction efficiency into primary T lymphocytes has limited clinical application of existing protocols. Recently, gene transfer rates > 50% have been achieved facilitating clinical studies. More attention is thus being focused on the ability of gene-modified cells to carry out innate as well as conferred functions in vivo and the influence of culture conditions, retroviral vector and host response thereon.",
author = "{Ayuketang Ayuk}, Francis and Zander, {A R} and B Fehse",
year = "2001",
language = "Deutsch",
volume = "1",
pages = "325--337",
number = "4",

}

RIS

TY - JOUR

T1 - T lymphocytes as targets of gene transfer with Moloney-type retroviral vectors.

AU - Ayuketang Ayuk, Francis

AU - Zander, A R

AU - Fehse, B

PY - 2001

Y1 - 2001

N2 - Peripheral T lymphocytes are a target of choice for many gene therapeutic strategies. Retrovirus-mediated transduction allows genomic integration and long-term expression of transgenes in target cells. Over many years, low transduction efficiency into primary T lymphocytes has limited clinical application of existing protocols. Recently, gene transfer rates > 50% have been achieved facilitating clinical studies. More attention is thus being focused on the ability of gene-modified cells to carry out innate as well as conferred functions in vivo and the influence of culture conditions, retroviral vector and host response thereon.

AB - Peripheral T lymphocytes are a target of choice for many gene therapeutic strategies. Retrovirus-mediated transduction allows genomic integration and long-term expression of transgenes in target cells. Over many years, low transduction efficiency into primary T lymphocytes has limited clinical application of existing protocols. Recently, gene transfer rates > 50% have been achieved facilitating clinical studies. More attention is thus being focused on the ability of gene-modified cells to carry out innate as well as conferred functions in vivo and the influence of culture conditions, retroviral vector and host response thereon.

M3 - SCORING: Zeitschriftenaufsatz

VL - 1

SP - 325

EP - 337

IS - 4

M1 - 4

ER -